EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Reduced cytochrome P-450 (CYP) 2D6 activity and Plasmodium vivax malaria risk in Amazonians: A retrospective, population-based cohort study

Rodrigo M Corder, Maria Carolina S B Puça, Carlos A Prete, Winni A Ladeia, Priscila T Rodrigues, Igor C Johansen, Tais Nobrega de Sousa, Marcelo U Ferreira iD, Mâncio Lima Cohort Study Working Group

PLOS Neglected Tropical Diseases · 27.03.2026 · 20 (3) · e0014160

DOI: 10.1371/journal.pntd.0014160 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 27.03.2026. Verfasst von Rodrigo M Corder und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Malaria, Vivax, Cytochrome P-450 CYP2D6. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, National Institute of Allergy and Infectious Diseases, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primaquine (PQ) is the only widely available drug that eliminates latent hypnozoites, thereby preventing relapses of Plasmodium vivax malaria. Because PQ biotransformation mediated by the cytochrome P-450 (CYP) isoenzyme CYP2D6 is required for therapeutic activity, patients with reduced CYP2D6 activity can experience relapse despite treatment. The minimum level of CYP2D6 activity for adequate anti-relapse PQ efficacy is unknown. Methods and findings We conducted a retrospective, population-based cohort study in the main malaria hotspot of Brazil. We fitted time-to-event data from cohort participants who experienced vivax malaria, using Cox proportional hazards models, to explore how genotype-determined CYP2D6 activity, expressed as activity scores (AS), modulates the risk of P. vivax recurrence within 6 months after treatment with chloroquine and PQ (total dose, 3.5 mg/kg). We analyzed community-wide P. vivax malaria incidence data, using a multivariable negative binomial regression model, to quantify the impact of reduced CYP2D6 activity on the overall risk of vivax malaria, whether from relapses or new infections. Among 466 P. vivax -infected cohort participants , those with null/low CYP2D6 activity (AS ≤ 0.25), but not participants with intermediate CYP2D6 activity (AS from 0.5 to 1.0), had twice the risk of recurrence compared to an AS > 1.0 (hazard ratio = 2.22, P = 0.004). However, vivax malaria incidence did not differ significantly across CYP2D6 activity levels during 5 years of follow-up of 997 Amazonians exposed to intense transmission (mean, 26.6 vivax malaria cases/100 person-years). These findings suggest that the excess of relapses among people with severely reduced CYP2D6 activity adds relatively little to the overall burden of vivax malaria episodes.

Conclusion

Amazonians with an AS ≤ 0.25, but not necessarily those with intermediate CYP2D6 activity, have a greater risk of recurrence after a PQ-treated P. vivax infection and require alternative relapse suppression regimens for the radical cure of vivax malaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria, VivaxCytochrome P-450 CYP2D6HumansRetrospective StudiesBrazilFemaleMalePrimaquineAdultAntimalarialsAdolescentMiddle AgedYoung AdultPlasmodium vivaxChloroquineRecurrenceChildGenotypeChild, PreschoolAgedCohort Studies

Substanzen

Cytochrome P-450 CYP2D6PrimaquineAntimalarialsChloroquine

Autor:innen und Institutionen

  • Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom.
  • Global Health and Tropical Medicine (GHTM), Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.
  • Molecular Biology and Malaria Immunology Research Group, René Rachou Institute, Fiocruz, Belo Horizonte, Brazil.
  • Department of Microbiology, Tumour and Cell Biology, Karolinska Institute, Solna, Sweden.
  • Department of Communications, School of Electrical and Computer Engineering, State University of Campinas, Campinas, Brazil.

ORCID-Profile: Marcelo U Ferreira

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • National Institute of Allergy and Infectious Diseases
  • Fundação para a Ciência e a Tecnologia
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico
  • Eric and Wendy Schmidt AI in Science Global Faculty fellowship
  • Coordenação de Aperfeiçoamento de Pessoal de NÃvel Superior

Zitieren

APA

Corder, R. M., Puça, M. C. S. B., Prete, C. A., Ladeia, W. A., Rodrigues, P. T., Johansen, I. C., de Sousa, T. N., Ferreira, M. U., & Mâncio Lima Cohort Study Working Group (2026). Reduced cytochrome P-450 (CYP) 2D6 activity and Plasmodium vivax malaria risk in Amazonians: A retrospective, population-based cohort study. PLOS Neglected Tropical Diseases, 20(3), e0014160. https://doi.org/10.1371/journal.pntd.0014160

Vancouver

Corder RM, Puça MCSB, Prete CA, Ladeia WA, Rodrigues PT, Johansen IC, et al. Reduced cytochrome P-450 (CYP) 2D6 activity and Plasmodium vivax malaria risk in Amazonians: A retrospective, population-based cohort study. PLOS Neglected Tropical Diseases. 2026;20(3):e0014160. doi:10.1371/journal.pntd.0014160

BibTeX
@article{Corder2026,
  author = {Corder, Rodrigo M and Puça, Maria Carolina S B and Prete, Carlos A and Ladeia, Winni A and Rodrigues, Priscila T and Johansen, Igor C and de Sousa, Tais Nobrega and Ferreira, Marcelo U and Mâncio Lima Cohort Study Working Group, Mâncio Lima Cohort Study Working Group},
  title = {Reduced cytochrome P-450 (CYP) 2D6 activity and Plasmodium vivax malaria risk in Amazonians: A retrospective, population-based cohort study},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {e0014160},
  doi = {10.1371/journal.pntd.0014160}
}
Kostenlos starten →